GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of EUR 92.95 billion. The enterprise value is 109.05 billion.

Market Cap	92.95B
Enterprise Value	109.05B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Feb 19, 2026

Share Statistics

Current Share Class	3.99B
Shares Outstanding	n/a
Shares Change (YoY)	-0.60%
Shares Change (QoQ)	-0.39%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	87.63%
Float	3.86B

Valuation Ratios

The trailing PE ratio is 14.19 and the forward PE ratio is 10.96.

PE Ratio	14.19
Forward PE	10.96
PS Ratio	2.48
PB Ratio	5.08
P/TBV Ratio	n/a
P/FCF Ratio	12.68
P/OCF Ratio	10.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.18, with an EV/FCF ratio of 14.88.

EV / Earnings	16.64
EV / Sales	2.89
EV / EBITDA	8.18
EV / EBIT	9.99
EV / FCF	14.88

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.11.

Current Ratio	0.82
Quick Ratio	0.50
Debt / Equity	1.11
Debt / EBITDA	1.54
Debt / FCF	2.78
Interest Coverage	14.36

Financial Efficiency

Return on equity (ROE) is 43.31% and return on invested capital (ROIC) is 26.53%.

Return on Equity (ROE)	43.31%
Return on Assets (ROA)	9.79%
Return on Invested Capital (ROIC)	26.53%
Return on Capital Employed (ROCE)	23.78%
Weighted Average Cost of Capital (WACC)	5.65%
Revenue Per Employee	560,227
Profits Per Employee	98,027
Employee Count	66,841
Asset Turnover	0.54
Inventory Turnover	1.54

Taxes

In the past 12 months, GSK plc has paid 1.27 billion in taxes.

Income Tax	1.27B
Effective Tax Rate	15.02%

Stock Price Statistics

The stock price has increased by +41.78% in the last 52 weeks. The beta is 0.35, so GSK plc's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+41.78%
50-Day Moving Average	24.15
200-Day Moving Average	20.46
Relative Strength Index (RSI)	42.29
Average Volume (20 Days)	65,796

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of EUR 37.45 billion and earned 6.55 billion in profits. Earnings per share was 1.59.

Revenue	37.45B
Gross Profit	27.19B
Operating Income	10.83B
Pretax Income	8.48B
Net Income	6.55B
EBITDA	12.99B
EBIT	10.83B
Earnings Per Share (EPS)	1.59

Balance Sheet

The company has 3.92 billion in cash and 20.39 billion in debt, giving a net cash position of -16.47 billion.

Cash & Cash Equivalents	3.92B
Total Debt	20.39B
Net Cash	-16.47B
Net Cash Per Share	n/a
Equity (Book Value)	18.29B
Book Value Per Share	4.68
Working Capital	-4.45B

Cash Flow

In the last 12 months, operating cash flow was 8.87 billion and capital expenditures -1.55 billion, giving a free cash flow of 7.33 billion.

Operating Cash Flow	8.87B
Capital Expenditures	-1.55B
Depreciation & Amortization	2.18B
Net Borrowing	1.46B
Free Cash Flow	7.33B
FCF Per Share	n/a

Margins

Gross margin is 72.61%, with operating and profit margins of 28.92% and 17.50%.

Gross Margin	72.61%
Operating Margin	28.92%
Pretax Margin	22.66%
Profit Margin	17.50%
EBITDA Margin	34.70%
EBIT Margin	28.92%
FCF Margin	19.57%

Dividends & Yields

This stock pays an annual dividend of 0.76, which amounts to a dividend yield of 3.28%.

Dividend Per Share	0.76
Dividend Yield	3.28%
Dividend Growth (YoY)	5.48%
Years of Dividend Growth	2
Payout Ratio	44.86%
Buyback Yield	0.60%
Shareholder Yield	3.88%
Earnings Yield	7.05%
FCF Yield	7.88%

Dividend Details

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 19, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	7